[Treatment strategy in asthma: is the aim symptom reduction or controlling exacerbations?]
Asthmatic patients with recurrent exacerbations may benefit from the single maintenance and reliever therapy (SMART) strategy, whilst patients with persistent symptoms may benefit from the addition of a long-acting muscarin antagonist (LAMA) to inhaled steroid therapy (with or without a long-acting beta2-agonist). However, an integrated approach is first needed to confirm diagnosis and to identify non-pharmacological, treatable traits.